![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Nosch Labs Private Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Ciprofibrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-263 - Rev 00
This Chemical Type CEP, issued on June 12, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2013 associated with this CEP further emphasizes